Search
    Skip to main content
    Advertisement

    GlaxoSmithKline

    1. Business
    2. Pharmaceuticals
    3. GlaxoSmithKline
    GSK's Exdensur gets green light from European Commission ShareCast03:34
    GSK Discloses ads Vesting and Tax-Related Share Sale by U.S. President TipRanks10:33
    GSK wins dual EU approval for its ultra-long-acting biologic Exdensur European Pharmaceutical Review08:14
    £1,000 buys 11,500 shares in this red hot healthcare penny stock that’s smashing GSK Motley Fool (UK)05:29
    JAX-NYSCF collaborates with GSK to advance human cellular models of neurodegenerative disease News-Medical.Net14:02
    EU approval for new asthma drug Exdensur lifts GSK pharmaphorum06:47
    ViiV Healthcare showcases long-acting HIV innovation and potential of ultra long-acting… Business Wire (Press Release)08:07

    Latest News

    In the last 2 hours
    See what the epic GSK share price recovery has done to £10,000 in the last year Motley Fool (UK)01:59
    Yesterday
    JAX-NYSCF collaborates with GSK to advance human cellular models of neurodegenerative disease News-Medical.Net14:02 17-Feb-26
    GSK Discloses ADS Vesting and Tax-Related Share Sale by U.S. President TipRanks10:33 17-Feb-26
    GSK wins dual EU approval for its ultra-long-acting biologic Exdensur European Pharmaceutical Review08:14 17-Feb-26
    JAX-NYSCF Collaborative and GSK Announce Collaboration to Advance Translational Models for… PR Newswire (Press Release)08:08 17-Feb-26
    ViiV Healthcare showcases long-acting HIV innovation and potential of ultra long-acting… Business Wire (Press Release)08:07 17-Feb-26
    GSK starts GBP450 million buyback tranche as EU approves Exdensur drug London South East07:59 17-Feb-26
    EU approval for new asthma drug Exdensur lifts GSK pharmaphorum06:47 17-Feb-26
    Europe Clears GSK's New Twice-Yearly Asthma Treatment Benzinga06:38 17-Feb-26
    £1,000 buys 11,500 shares in this red hot healthcare penny stock that’s smashing GSK Motley Fool (UK)05:29 17-Feb-26
    GSK's Exdensur gets green light from European Commission ShareCast03:34 17-Feb-26
    GSK Wins EU Nod for First Ultra-Long-Acting Biologic in Severe Asthma TipRanks02:24 17-Feb-26
    In the last 7 days
    ‘The default way of thinking’: Haleon’s outgoing CMO on cementing marketing’s role Marketing Week08:20 16-Feb-26
    GSK plc (LON:GSK) Stock Goes Ex-Dividend In Just Four Days Simply Wall St03:52 14-Feb-26
    Can GSK use artificial intelligence to break the R&D trap? Investors Chronicle09:41 13-Feb-26
    GSK Advances Pediatric Antibiotic Strategy With New Gepotidacin Trial TipRanks11:35 12-Feb-26
    Noteworthy ETF Inflows: FENI, GSK, BTI, RIO Nasdaq11:01 12-Feb-26
    GSK, Teva quietly settle Coreg 'skinny label' dispute after long legal back-and-forth FiercePharma11:46 11-Feb-26
    GSK, Teva End High-Stakes ’Skinny Label’ Fight Over Coreg Patent Bloomberg Law11:15 11-Feb-26
    GSK discloses senior executive payouts from deferred share awards TipRanks10:36 11-Feb-26
    In the last month
    GSK, Teva Settle 'Skinny Label' Heart Medication Suit Law36020:21 10-Feb-26
    GSK Rsv vaccine Arexvy accepted for review in China for adults over 60 London South East05:23 10-Feb-26
    China's Cde accepts GSK's regulatory filing for Rsv vaccine ShareCast02:50 10-Feb-26
    GSK: China's Cde To Review Regulatory Application For Arexvy RTT News02:48 10-Feb-26
    Invasive Fungal Infections Market to Witness Upsurge in Growth at a CAGR of 11.4% (in the US)… PR Newswire (Press Release)17:33 9-Feb-26
    Broker tips: Dunelm, GSK, Greggs ShareCast10:44 9-Feb-26
    JP Morgan raises target price on GSK ShareCast08:45 9-Feb-26
    Citi lifts GSK target price but keeps neutral stance after rally Proactive Investors (US)07:17 9-Feb-26
    GlaxoSmithKline Pharma Q3 profit up 29 pc at Rs 296 cr The Business Standard06:12 9-Feb-26
    Q3 Results Today Live: BSE, Zydus Lifesciences, Aurobindo Pharma, Linde India, Axiscades Tech, GlaxoSmithKline Pharma,… The Hindu Business Line23:06 8-Feb-26
    Q3 results: Pfizer, Zydus Lifesciences, Aurobindo Pharma, 181 more on Feb 9 The Business Standard21:25 8-Feb-26
    ‘Old school’ UK stocks like Lloyds, GSK, and Vodafone are making a huge comeback. Here are 2 to … Motley Fool (UK)03:14 8-Feb-26
    GSK Gets EU Approval for Expanded Use of Nucala in COPD Zacks12:50 6-Feb-26
    In brief: GSK Chair Jonathan Symonds buys GBP53,000 in shares London South East11:20 6-Feb-26
    Director dealings: GSK chairman raises stake London South East10:08 6-Feb-26
    GSK’s Nucala green lit for COPD in expanded EU approval European Pharmaceutical Review07:26 6-Feb-26
    ShoreCap says GSK has cracked it and the £40bn prize is now in sight Proactive Investors (UK)05:15 6-Feb-26
    New Oxford-led initiative launches to train future leaders in transformative technologies for pharmaceutical research University of Oxford04:27 6-Feb-26
    EU regulator greenlights GSK lung disease therapy Nucala London South East03:42 6-Feb-26
    London briefing: UK house prices rise more than expected in January London South East03:01 6-Feb-26
    EU gives GSK's Nucala green light for use in uncontrolled COPD ShareCast02:46 6-Feb-26
    GSK’s H5N1 mRNA Flu Vaccine Trial Reaches Completion: What Investors Should Watch Next TipRanks11:32 5-Feb-26
    GSK Earnings: Strong Performance Across Specialty Medicines Boosts Full-Year Outlook Morningstar10:09 5-Feb-26
    Pharma chameleon: GSK celebrates post-Zantac comeback Punchline Magazine05:37 5-Feb-26
    GSK shares healthy after annual results interactive investor05:07 5-Feb-26
    GSK sees profits rise but fears slowdown in growth Yorkshire Post03:07 5-Feb-26
    GSK’s oncology and HIV drugs drive 7% sales rise in 2025 Pharmaceutical Technology13:41 4-Feb-26
    GSK beat the numbers, but the real story was the guidance Proactive Investors (UK)10:31 4-Feb-26
    As CEO, Luke Miels wants GSK to be more ‘product-centric’ FiercePharma09:51 4-Feb-26
    GSK's Q4 Earnings & Sales Beat Estimates, Stock Up on '26 Outlook Zacks09:43 4-Feb-26
    GSK Bets On New Launches And R&D Acceleration As Sales Headwinds Remain Scrip Pharma Intelligence09:10 4-Feb-26
    GSK Stock Smashes 52-Week High On Strong Quarter, Dividend Hike Benzinga08:20 4-Feb-26
    GSK delivers in new CEO Miels' first financial update pharmaphorum08:17 4-Feb-26
    GSK (GSK) Surpasses Q4 Earnings and Revenue Estimates Zacks08:11 4-Feb-26
    GSK starts to show real profit improvement Investors Chronicle07:56 4-Feb-26
    GSK boosted by specialty drugs, end to Zantac fallout France 2407:29 4-Feb-26
    London market midday: FTSE 100 strengthens as Beazley and GSK rise London South East07:11 4-Feb-26
    FTSE shrugs off AI chaos Investors Chronicle07:10 4-Feb-26
    AI hits stocks & GSK: Markets live blog Investors Chronicle05:53 4-Feb-26
    GSK posts higher profits but indicates sales growth to slow in 2026 Evening Standard04:18 4-Feb-26
    GSK optimistic for 2026 after fourth-quarter results beat forecast London South East03:58 4-Feb-26
    GSK expects softer sales growth for 2026 RTE03:54 4-Feb-26
    GSK expects softer 2026 sales growth as new CEO Miels prepares change in course Yahoo! UK & Ireland03:47 4-Feb-26
    GSK Targets Long-Term Growth as Late-Stage Assets Near Commercialization Investing.com UK03:27 4-Feb-26
    GSK delivers solid 2025 results, reaffirms growth outlook for 2026 Proactive Investors (US)03:18 4-Feb-26
    London briefing: Zurich agrees terms for GBP8.0 billion Beazley offer London South East03:07 4-Feb-26
    GSK sees slower sales growth in 2026 as patent loss looms ShareCast02:54 4-Feb-26
    GSK sees turnover growth slowing in FY26, DCC Q3 adjusted operating profits grow ShareCast02:42 4-Feb-26
    GSK forecasts slower sales growth in 2026 Yahoo! US02:13 4-Feb-26
    London market early call: FTSE 100 to rise with GSK results due London South East01:56 4-Feb-26
    Wednesday preview: GSK results among the highlights ShareCast11:01 3-Feb-26
    Why GSK (GSK) is a Top Value Stock for the Long-Term Zacks10:46 3-Feb-26
    Insights Ahead: GSK's Quarterly Earnings Benzinga09:15 3-Feb-26
    GSK full-year earnings: can the pharma giant deliver on post... IG06:48 3-Feb-26
    GSK to cut 50 jobs at Stevenage site as part of overhaul The Comet, Hertfordshire05:05 3-Feb-26
    GSK kicks out of Wave's AATD programme pharmaphorum04:49 3-Feb-26
    Overhaul sees GSK slash 350 R&D jobs Business Plus Online02:35 3-Feb-26
    Wave Life Sciences Reclaims Rare Disease Drug From GSK, Targets Faster FDA Path Benzinga14:19 2-Feb-26
    GSK to cut up to 350 R&D jobs across UK, US ShareCast12:37 2-Feb-26
    Drugs giant to axe up to 350 R&D jobs across the US and UK Yahoo! UK & Ireland11:22 2-Feb-26
    GSK cutting jobs in UK and US as part of ongoing R&D changes The Independent09:42 2-Feb-26
    GSK walks away from pioneering Wave RNA editing drug BioPharma Dive09:29 2-Feb-26
    Week Ahead: GSK, BT, Shell, Vodafone, Anglo American interactive investor08:29 2-Feb-26
    Top FTSE 100 Index shares to watch: BT Group, Vodafone, Shell, GSK Invezz03:25 30-Jan-26
    Here's Why GSK (GSK) is a Strong Growth Stock Zacks10:55 28-Jan-26
    FTSE 100: European stocks dragged down as dollar rallies and gold exert pull Proactive Investors (US)06:07 28-Jan-26
    Jan. 27 Business Watch: Vioneo moves project to China; GSK to buy Rapt Therapeutics for $2.2 billion Chemical & Engineering News15:05 27-Jan-26
    Broker tips: Zotefoams, Burberry, AstraZeneca, GSK ShareCast10:57 27-Jan-26
    Here's Why GSK (GSK) is a Strong Momentum Stock Zacks10:56 27-Jan-26
    Citi starts AstraZeneca at 'buy', takes 'neutral' stance on GSK ShareCast08:34 27-Jan-26
    GSK’s Arexvy RSV vaccine receives expanded EC approval for use in adults PMLiVE08:08 27-Jan-26
    GSK, Takeda among wave of new licensees in booming drug delivery space IAM02:19 27-Jan-26
    Korea's Alteogen inks $265 M deal with GSK to develop subcutaneous formulation of Dostarlimab BioSpectrum Asia01:51 27-Jan-26
    GSK's Rsv treatment, Arexvy, secures approval for wider use in EU London South East03:30 26-Jan-26
    London briefing: GSK wins EU nod for Rsv shot; Spire in early talks London South East03:09 26-Jan-26
    GSK: Arexvy Vaccine Receives European Commission Approval For Use In All Adults RTT News02:52 26-Jan-26
    EU clears GSK's Rsv vaccine for use in all adults, Spire confirms early talks with Bridgepoint and Triton ShareCast02:29 26-Jan-26
    GSK vaccine given green light for all adults in Europe London South East02:29 26-Jan-26
    The 5 most popular FTSE 100 stocks on AJ Bell to begin 2026 Motley Fool (UK)01:56 26-Jan-26
    Weekly Buzz: Iobt Slashes Jobs; GSK To Acquire rapt; Cort's Ovarian Cancer Study Meets Goals RTT News10:05 23-Jan-26
    In brief: GSK drug approved in China to treat uncontrolled asthma London South East05:18 23-Jan-26
    Pharma Bets Big on AI Platforms with Flurry of New Year... Genetic Engineering and Biotechnology News14:50 22-Jan-26
    GSK Halts Early-Stage Sickle Cell Study, Tweaking the Risk Profile of Its Rare Disease Pipeline TipRanks11:31 22-Jan-26
    ii view: GSK makes exciting food allergy acquisition interactive investor09:37 22-Jan-26
    GSK's Rockville R&D campus slated for big renovation Washington Business Journal15:29 21-Jan-26
    GSK to Boost Respiratory & Immunology Pipeline With $2.2B RAPT Buyout Zacks11:26 21-Jan-26
    GSK Velu appointed Chairman of Ficci Tamil Nadu State Council The Hindu Business Line10:20 21-Jan-26
    GSK Awards $2M in COiMMUNITY Initiative Grants to Help Close Vaccination Gaps, Commits $3M for… Business Wire (Press Release)10:10 21-Jan-26
    Sherry Knowles IAM09:26 21-Jan-26
    GSK acquires food allergy firm Rapt Therapeutics for $2.2bn European Pharmaceutical Review08:02 21-Jan-26
    In brief: Rtw Biotech welcomes GSK deal to buy rapt Therapeutics London South East06:38 21-Jan-26
    GSK and Shionogi agree to replace Pfizer's stake in ViiV Healthcare BioSpectrum Asia01:00 21-Jan-26
    Why Rapt Therapeutics Stock Soared Today The Motley Fool17:42 20-Jan-26
    GSK gaining Rapt’s allergy drug in $2.2B M&A BioWorld17:26 20-Jan-26
    GSK licenses Alteogen enzyme in bid to develop subQ Jemperli FiercePharma14:51 20-Jan-26
    view more headlines
    18 Feb 01:59

    GlaxoSmithKline News

    NewsNow aims to be the world's most accurate and comprehensive aggregator of GlaxoSmithKline news, covering the latest share price, company announcements, vaccine trials, product news and more from the best online publications. Every story from every site is brought to you automatically and continuously 24/7, within around 10 minutes of publication.
    Read more

    Pharmaceuticals Top Stories

    Breaking: Bayer AG unveils $7.3B Deal for roundup users Law36012:28
    GSK wins dual EU approval for its ultra-long-acting biologic Exdensur European Pharmaceutical Review08:14
    STAT Plus: Ocular’s experimental eye drug beats low dose of Regeneron’s Eylea in late-stage… STAT07:02
    Stada earmarks €85M to build out Middle East production hub in Saudi Arabia FiercePharma16:23
    Harnessing AI to optimize the development of new protein manufacturing processes News-Medical.Net12:51

    Business Top Stories

    Stock market today, Feb. 17: Apple rebounds as AI strategy heads into high-profile march event The Motley Fool17:34Apple AI Top Tech Brands
    Why Apple stock rose today The Motley Fool22:08Apple AI Top Tech Brands
    Activist shareholder demands turnaround at Norwegian Cruise Line Holdings The Maritime Executive17:49Norwegian Cruise Line Norway Asset Management
    Norwegian locks in three-ship Fincantieri deal, secures yard slots through 2037 gCaptain19:56Norwegian Cruise Line Norway Asset Management
    Warren Buffett's Berkshire Hathaway bought shares of The New York Times. Should you? The Motley Fool00:10Warren Buffett Berkshire Hathaway New York
    Warren Buffett's company invests in New York Times six years after selling newspapers ABC News19:47Warren Buffett Berkshire Hathaway New York
    3 Top dividend stocks for passive income Barchart16:30
    This high‑yield dividend could make patient investors rich in retirement The Motley Fool01:42
    CFTC tells 9th cir. States overstep prediction markets authority Bloomberg Law18:03CFTC Business (US)
    'See you in Court': CFTC chair defends jurisdiction as states fight prediction markets Decrypt10:15CFTC Business (US)
    Publication filters

    Headline Density

    Sorry, no headlines or news topics were found. Please try different keywords.